Get informed when a big investor buys or sells
+ Follow142.22%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Aion Therapeutic posts a ROE of 142.22%. That is above the sector sector average of 11.3%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a ROE near 11.3% is typical. Aion Therapeutic's 142.22% is higher that level. That is roughly 1159.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Aion Therapeutic's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 142.22%; use YoY and peer views to separate noise from signal.
Context for AION.CN's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.3%), and (3) consistency with growth and profitability. This page covers the first two; Aion Therapeutic's other metric pages and overview cover the third.